End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
21.69 CNY | +0.23% | -4.20% | +16.61% |
05-23 | CR Double-Crane Pharmaceutical's Unit Gets Nod to Market Schizophrenia Drug | MT |
05-08 | CR Double-Crane Pharmaceutical's Unit Gets Nod for Lidocaine Hydrochloride Injection | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.61% | 3.06B | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- 600062 Stock
- News China Resources Double-Crane Pharmaceutical Co.,Ltd.
- Henan Genuine Biotech Denies Report of COVID-19 Drug Now on Market